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INTRODUCTION {#s1}
============

Coding nucleotide sequences carry an integral message containing several different types of information for the various molecular mechanisms‏.^[@R1]^ Recent studies also suggest that beyond the amino-acid sequence lies an additional layer of information, hidden within the codon sequence, able to mediate local kinetics of translation.^[@R2]^ Studies of these hidden information in codon sequences, can reveal the molecular evolution of organisms, and provide insights into the functional categories and histories of genes in a genome.^[@R2]^ Codon-usage analysis can also contribute to understanding the interaction between RNA viruses and the immune response of the hosts.^[@R2]^

Although each codon is specific for only one amino acid (or one stop signal), the genetic code is described as degenerate, or redundant because a single amino acid may be coded by more than one codon. Such groups of codons coding for a single amino acid are known as synonymous codons. For instance, six synonymous codons can produce the amino acid leucine. By contrast, a non-degenerate code, like for the amino acids methionine and tryptophan, is one for one: each code is unique, producing one and only one output. In total, 18 of the 20 amino acids can be encoded by more than one codon and most of this degeneracy is found at the third position in a codon. Synonymous codons encoding for a particular amino acid are very well conserved over most species although a few small exceptions have been reported.^[@R3],[@R4]^

Codon usage bias refers to differences in the frequency of occurrence of synonymous codons in coding DNA. Different factors have been proposed to explain the preferential usage of a subset of synonymous codons, including biased mutation pressure,^[@R5]^ difference in mutational bias between the leading and lagging strands of DNA replication,^[@R6],[@R7]^ and natural selection for optimizing translation process (translational selection).^[@R8]^ While some codons are preferentially used in highly expressed genes, some codons are almost absent. These codons are referred to in the literature as rare, unflavored or low usage codons. Some reports indicate synonymous codons used with low frequency tend to have depleted concentration of tRNAs.^[@R9]-[@R11]^ Dereased tRNAs concentration, influence ribosomes to pause at rare codons until the rare activated tRNA brings the next amino acid to the growing polypeptide.^[@R12],[@R13]^ It was observed that the distribution of rare triplets along mRNAs is definitely non-uniform. The observation that rare codons are not randomly distributed, but rather organized in large clusters^[@R14]^ across species support the existence of a selective evolutionary pressure.^[@R15]^ The clustering of rare or un-favored codons near the start codon was first identified by Ikemura^[@R16]^ in the highly expressed ribosomal protein genes rplK, rplJ, and rpsM. This was attributed to some functional constraint, perhaps a signal for special regulation.^[@R17]^ Several studies focused on identifying rare codons in protein sequences and replacing them with frequent synonymous ones.^[@R18]^ The results of studies, based on the identity, density and location of the rare codons, were diverse: change in substrate specificity,^[@R18]^ decrease in protein solubility,^[@R19]^ activation of a gene designed to detect misfolded proteins ^[@R19]^ and a decrease of a protein's specific activity.^[@R20]^ It has been proposed that translational pauses may have evolved to secure the independent functionally competent folding of some regions of polypeptide chains during their synthesis.^[@R21]^

The hepatitis C virus (HCV) is a small, enveloped, single-stranded, positive-sense RNA virus. It is a member of the hepacivirus genus in the family Flaviviridae.^[@R22]^ It consists of a 9.6 kb RNA, which contains an open reading frame (ORF) encoding a polyprotein, flanked by un-translated regions (UTR) at both ends .^[@R23],[@R24]^ The HCV genome encodes a polyprotein precursor of about 3000 amino acids.^[@R25]^ The polyprotein is cleaved by the cellular signal peptidase and virally encodes two proteases into at least 10 mature proteins; core, envelope glycoprotein 1 (E1), E2, p7, nonstructural protein 2 (NS2), NS3, NS4A, NS4B, NS5A, and NS5B.^[@R26],[@R27]^ No prophylactic HCV vaccine is currently available and increasing efforts are, therefore, needed in the development of an effective vaccine against HCV.

Previously, two rare codons have been detected in the HCV.^[@R28]^ Because of an increasing amount of evidence suggesting that rare codon clusters are functionally important for protein activity,^[@R29]^ in the present study for the first time we studied the rare codon clusters and their locations in structures of HCV proteins. For this, we identified the Pfam accession number of 10 mature HCV proteins; core, E1, E2, p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B by use of HCVpro database (HCV protein interaction database).^[@R30]^ Subsequently, these Pfams accession numbers were analyzed in Sherlocc program.^[@R2]^ Sherlocc program detects statistically relevant conserved rare codon clusters and produces an HTML output.^[@R2]^ Analyses of these sequences show that several sites of HCV genome (NS2, NS3, NS4B, NS5A, and NS5B) have a rare codon cluster. Subsequently, the structures of TrEMBL entries that are reported in the output of Sherlocc program were studied in PDB database. The results of these studied shows that PDB structures of HCV proteins are not complete just as TrEMBL entries reported in Sherlocc Program outputs. For this reason, by submission of NS2, NS3, NS4B, NS5A, and NS5B sequences with these TrEMBL entries in Swiss Model Alignment interface protein modeling server,^[@R31]^ 3D structure models were obtained. 3D structures of the HCV proteins and locations of rare codon clusters were visualized and studied using PyMOL software.^[@R32]^ The major influence of codon usage is on local translation rate, and large clusters will a greater effect on protein production than an equivalent number of randomly scattered rare codons.^[@R15],[@R33],[@R34]^ Reports of improved folding yield or protein activity due to translational pausing ^[@R35],[@R36]^ infer that potential factors might lead to the enrichment of rare codon clusters. These results imply the role of rare codon clusters in all aspects of protein expression: mRNA stability, folding, secretion, and interactions with partner proteins.^[@R15]^ The results of these studies show that one hidden layer of codon usage information lies in the rare codon clusters and we believe studying rare codon clusters and their locations in the structure of HCV mRNA and proteins may help in the development of new and effective drugs in the future.

MATERIALS AND METHODS {#s2}
=====================

Detection of rare codon clusters {#s2-1}
--------------------------------

The protein family accession number (Pfam) of 10 mature HCV proteins; core, E1, E2, p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B were identified using HCVpro database ^[@R30]^ and listed in [table 1](#T1){ref-type="table"}. The analysis and detection of the codon clusters of these Pfam IDs was done in Sherlocc program. For this, Sherlocc retrieves the nucleotide sequence of every protein in each Pfam protein family alignments from the European Nucleotide Archive (ENA) database.^[@R37]^ Then, using the appropriate translation table the correspondence of the nucleotide sequence with the amino-acid sequence provided in the Pfam alignment is verified and the specie codon usage frequencies are retrieved using the Kazusa codon usage frequency online database.^[@R38]^ To detect rare codon clusters, a 7 codon-wide window, is centered at every position of the alignment, and averages all codon usage frequencies inside the 7 codon-wide windows. This average calculated across all proteins of the alignment has subsequently the net effect of assuring that only positions that are rare across the majority of the members of the family are retained.^[@R2]^ From this, the threshold can be chosen and will allow us to discriminate positions of the alignment occupied by rare codons. All codon usage frequency averages under this threshold are tagged as slow.^[@R2]^ Estimated locus's of these rare codon clusters in HCV genomic RNA is shown in [figure 1](#F1){ref-type="fig"} and HTML output of Sherlocc program is shown in [figure 2](#F2){ref-type="fig"}. The rare codon clusters characteristics in HCV proteins are listed in [table 2](#T2){ref-type="table"}.

###### The characteristic of PFAM ID and rare codon clusters in HCV.

  ----------------- ----------------- -------------------------------- -----------------------------------
  **HCV protein**   **PFAM ID**       **Number rare codon clusters**   **codon usage average threshold**

  Core              Pf0154, Pf01543   2                                18

  E1                PF01539           0                                \-

  E2                PF01560           0                                \-

  P7                Not detected      \-                               \-

  NS2               PF01538           1                                18

  NS3               PF02907           3                                18

  NS4A              PF01006           0                                \-

  NS4B              PF01001           1                                18

  NS5A\             Pf01506,\         0\                               \-\
  NS5A\             Pf08300,\         1\                               18\
  NS5A              Pf08301           1                                18

  NS5B              PF00998           11                               18
  ----------------- ----------------- -------------------------------- -----------------------------------
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###### The output of Sherlocc program and rare codon clusters characteristics in HCV proteins.

  ----------------- ------------- --------------------------------- ------------------------------ --------------------- ------------------------------------- ---------------------- --------------------------------- ---------------------- ----------------------------------------------------------
  **HCV protein**   **PFAM ID**   **Swiss-Prot or TrEMBlentries**   **Organism**                   **Number proteins**   **Residue length of the alignment**   **RCC^\*^ Position**   **RCC Usage Frequency Average**   **RCC Middle Point**   **Fraction of the pfam occupied by rare codon clusters**

  Core              Pf0154        Q69422 (POLG_GBVB)                Hepatitis GB virus B           1                     76                                    24 -- 44 64 - 68       16.028\                           33\                    0.3421052632
                                                                                                                                                                                      17.354                            65                     

  NS2               PF01538       A8DF36_9HEPC                      Hepatitis C virus subtype 1b   6                     203                                   36-45                  17.983                            40                     0.0492610837

  NS3               PF02907       Q9QIX6_9HEPC                      Hepatitis C virus subtype 1b   3                     150                                   7-14\                  17.305\                           10\                    0.1200000000
                                                                                                                                                               41-45\                 17.679\                           42\                    
                                                                                                                                                               77-81                  16.938                            75                     

  NS4B              PF01001       Q69422**(**POLG_GBVB)             Hepatitis GB virus B           3                     199                                   59-63                  17.318                            60                     0.0251256281

  NS5A              Pf01506       \-                                \-                             \-                    \-                                    \-                     \-                                \-                     \-

                    Pf08300       Q1KL41-9HEPC                      Hepatitis C virus subtype 6a   8                     64                                    47-53                  16.873                            49                     0.1093750000

                    Pf08301       Q1KL34_9HEPC                      Hepatitis C virus subtype 6a   6                     103                                   84-87                  17.405                            85                     0.0388349515

  NS5B              PF00998       Q69422 (POLG_GBVB)                Hepatitis GB virus B           15                    545                                   3-7                    4                                 17.930                 0.1339449541

                                                                                                                                                               15-21                  17                                17.007                 

                                                                                                                                                               35-45                  39                                17.814                 

                                                                                                                                                               91-95                  92                                17.598                 

                                                                                                                                                               104-107                105                               16.697                 

                                                                                                                                                               116-119                117                               17.472                 

                                                                                                                                                               172-175                173                               17.261                 

                                                                                                                                                               316-322                318                               18.033                 

                                                                                                                                                               418-422                419                               17.196                 

                                                                                                                                                               439-448                443                               17.542                 

                                                                                                                                                               514-524                518                               17.675                 
  ----------------- ------------- --------------------------------- ------------------------------ --------------------- ------------------------------------- ---------------------- --------------------------------- ---------------------- ----------------------------------------------------------

^\*^RCC: Rare codon cluster.

Analysis of rare codon clusters in the structure of HCV proteins {#s2-2}
----------------------------------------------------------------

To investigate the position of rare codon clusters in the structure of HCV proteins, the structures of TrEMBL entries proteins that were reported in Sherlocc program were studied in PDB database. The results showed that PDB structures of HCV proteins and their sequences are not complete and are just as TrEMBL entries sequences reported in Sherlocc Program. For this reason, by submission of TrEMBL entries sequences of NS2, NS3, NS4B, NS5A, and NS5B in Swiss Model Alignment interface protein modeling server,^[@R31]^ 3D structure models were obtained. Modeled residue range, used templates, sequence identity and other detail information were listed in [table 3](#T3){ref-type="table"}. 3D structures of the HCV proteins and locations of rare codon clusters were visualized and studied using PyMOL software ^[@R32]^ as shown in [figures 3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}.

###### The characteristics of HCV protein modeling

  -------------------- --------------------------- ----------------------- ----------------------------- ------------- -------------------
  **HCV Protein**      **Modeled residue range**   **Based on template**   **Sequence Identity \[%\]**   **E value**   **QMEAN Z-Score**

  NS2                  27-59                       2kwtA                   87.88                         5.56e-10      -3.59

  NS3                  1 to 149                    4a1xA                   96.64                         5.69e-76      0.05

  NS5A-Q1KL41-9HEPC\   36 to 198\                  1zh1B\                  77.3\                         2.38e-71\     -0.93\
  NS5A-Q1KL34_9HEPC    36 to 198                   1zh1B                   76.69                         1.65e-71      -0.81
  -------------------- --------------------------- ----------------------- ----------------------------- ------------- -------------------
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RESULTS {#s3}
=======

Detection of rare codon clusters {#s3-1}
--------------------------------

With use of HCVpro database the Pfam accession numbers of 10 mature HCV proteins were identified. Pfam is a comprehensive collection of protein domains and families represented as multiple sequence alignments and as profile hidden Markov models.^[@R39]^ After detecting Pfam IDs of HCV proteins, these Pfams were studied in the Sherlocc program. Results of these studies show that this program did not identify rare codon clusters in the envelope glycoproteins 1 (E1), E2, p7 and nonstructural protein NS4A. By contrast the rare codon clusters were identified in the core, nonstructural protein NS2, NS3, NS4B, NS5A and NS5B. The HCVpro database^[@R30]^ detected two Pfams for core protein and analyzing the Pf01543 ID in the Sherlocc program detected no rare codon cluster while the Pf0154ID showed two rare codon clusters. For NS5A, the HCVpro database detected three Pfams (Pf01506, Pf08300 and Pf08301). Studying these Pfams shows that Pf01506 ID has no rare codon cluster while the rare codon clusters were identified in the Pf08300 and Pf08301 IDs. However in HCVpro database no Pfam was identified for P7 and therefore the Sherlocc program could not identify the rare codon cluster in this region of RNA sequence. By analyzing the PF01539, PF01560, PF01006 and Pf01506 IDs in this program, rare codon clusters were not detected in these regions of RNA sequences. However, Sherlocc program detects statistically relevant conserved rare codon clusters and more precise studies might be needed for proving these results. The Pfam ID, number of rare codon clusters and codon usage average threshold are listed in [table 1](#T1){ref-type="table"}.

The Sherlocc program produces an HTML output that reports the TrEMBL entries. Studying these TrEMBL entries showed that some of the relevant conserved rare codon clusters do not cover the TrEMBL entries from HCV proteins and eventually we gave up these rare codon clusters. According to this thread, we did not consider the results of Sherlocc program analysis for core, NS4B and NS5B Pfam IDs. The Pfam ID, Swiss-Prot or TrEMBL entries, organism, rare codon clusters position usage and other detail information are listed in [table 2](#T2){ref-type="table"}. It is important that rare codon cluster position reported in this table be based on the first TrEMBL entries.

Analysis positions of rare codon clusters in HCV mRNA sequences {#s3-2}
---------------------------------------------------------------

HCV has positive sense single-strand RNA genome. The genome composes a single open reading frame that is 9600 nucleotide bases long.^[@R25]^ This single open reading frame is translated to produce one protein product, which is then further processed to produce smaller active proteins. As previously mentioned, we identified six rare codon clusters in HCV genomic RNA found in the NS2, NS3 and NS5A regions of RNA. [Figure 1](#F1){ref-type="fig"} shows estimated locus's of these rare codon clusters in RNA genome.

Translation of mRNA is regulated by structural and non-structural RNA elements, and interactions with RNA-binding proteins.^[@R40]^ One of the significant features of viral genome translation is the identification of genetic elements, either RNA sequences or protein domains, which may modulate the viral genome translation. Previously, six HCV genome elements (GE) had been identified.^[@R41]^ One of these GE, GE4, encodes the 5' end of the viral NS5A gene that includes the membrane anchor domain.^[@R41]^ The interesting point is that one rare codon cluster was found in this genome element (GE4). However, the position of rare codon clusters and their structural patterns in RNA may be important in opening new research fields for extending the possible cures for many disorders or viral infections. [Figure 2](#F2){ref-type="fig"} show the HTML output from Sherlocc program that reports the TrEMBL entries and the characteristic of rare codon clusters.

Studying rare codon clusters in the structure of HCV proteins {#s3-3}
-------------------------------------------------------------

Knowledge of 3D structure is a useful prerequisite for understanding the role and function of proteins. Studying the location and roles of rare codon clusters on the three-dimensional structure of proteins, is a cornerstone in many aspects of modern biology. The possible roles for rare codon clusters are to produce multiple translational pauses during the synthesis of its catalytic domain,^[@R2]^ play a regulating role in folding catalytically important domains, and in protein structure and indirect folding.^[@R29],[@R42]^ Further, many results support the existence of a widespread functional role for rare codon clusters across species.^[@R2]^ As mentioned, six rare codon clusters were identified in HCV genome found in NS2, NS3 and NS5A of HCV proteins. Specific studies shows PDB structures of HCV proteins are not complete and are just as TrEMBL entries sequences reported in Sherlocc program outputs. Protein-protein blast show the rough location of rare codon clusters in these sequences but for precise studying of the location and role of rare codon clusters, it is necessary to gain 3D models from these sequences. To this end, by submitting sequences of NS2, NS3 and NS5A in Swiss Model alignment interface protein modeling server,^[@R31]^ 3D models of these proteins were obtained. The modeled residue range, template and other detailed information are listed in [table 3](#T3){ref-type="table"}.

The Sherlocc program identified TrEMBL entryA8DF36_9HEPCfor NS2. Using the Swiss-Model, these TrEMBL entry sequence were used for obtaining the 3D model of this protein. NS2, derived from the cleavage of NS2/3, inserted into the ER membrane through its N-terminal hydrophobic domain suggested containing multiple transmembrane segments.^[@R43]^ The NS2 protein has 217 residue and rare codon clusters found from amino acids 37 to 46 and in polyproteins extending from amino acids 846-855. The overall structure of NS2 was not determined and therefore the Swiss Model could not model the whole sequence. The structure of NS2 protein has been modeled previously and in this model amino acids from 27 to 49 formed trans-membrane α helix (TMH-2).^[@R43]^ Results of modeling show that this rare codon cluster is located in this trans-membrane α helix (TMH-2). [Figure 3](#F3){ref-type="fig"} shows the modeled NS2 and the position of rare codon clusters.

For NS3 protein, Sherlocc program identified TrEMBL entries Q9QIX6_9HEPC.The NS3 protein has 631 residue and three rare codon clusters found in polyproteins extending from amino acids 1062-1069, 1096-1100 and 1132-1136**.** NS3 is a multifunctional protein and the N-terminal domain (residues 1027--1119) contains eight β strands rather than six, including one strand contributed by NS4A.^[@R44]^ This array of b strands gives rise to a b sheet that superimposes with most of the distorted barrel found in the N-terminus of chymotrypsin.^[@R45]^ Result of modeling showed that these three rare codon clusters lie between strands A1-B1, E1-F and A2-B2 in N-terminal domain of NS3. [Figure 4](#F4){ref-type="fig"} shows the modeled NS3 and the position of rare codon clusters.

As mentioned, HCVpro database for NS5A detected three Pfams. For Pf01506 ID this database did not identify any rare codon cluster while for Pf08300 and Pf08301 IDs two rare codon clusters were identified. These rare codon clusters were found in different loci sequences of NS5A and Sherlocc program for NS5A revealed two TrEMBL entries; Q1KL41**-**9HEPC and Q1KL34_9HEPC. The protein was predicted to be mainly hydrophilic and contain no transmembrane helices.^[@R46]^ A recent study using bioinformatics assisted modeling suggested a three-domain organization with domain I (a.a. 1-213) located in the N-terminal region, and Domain II (a.a. 250-342) and Domain III (a.a. 356-447) in the C-terminal region.^[@R47]^ Analysis of the 3D model showed that these two rare codon clusters lie in domain I located in the N-terminal of NS5A HCV. [Figure 5](#F5){ref-type="fig"} shows the position of these rare codon clusters in the structure of NS5A HCV proteins.

DISCUSSION {#s4}
==========

The preliminary goal of this study was to perform a survey of rare codon clusters in the HCV genome and then identify the location of these clusters in the structure of HCV protein. Previous studies on the distribution of rare codons clusters were performed on a limited number of proteins or protein families.^[@R2]^ The Sherlocc program and the online Sherlocc Finder Interface are efficient tools that can be used to study the widespread translational pauses in protein families.^[@R2]^ Please note that clusters identified by Sherlocc were compared with cases foundin the literature.^[@R2]^ For example, in the Salmonella phage P22 tail spike protein in which rare codons were previously identified using the MinMax algorithm,^[@R15]^ Sherlocc also identified rare codon clusters in the Salmonella phage P22 tail-spike protein family (PF09251).^[@R2]^ Another case involved the chloramphenicol acetyl transferase (CAT) protein for which rare codon clusters were identified computationally in a multi-organism sequence alignment of this protein.^[@R42]^ The Sherlocc program also identified rare codon clusters in the CAT protein family (PF00302). In the present study, we used Sherlocc program to analyze rare codon clusters in HCV genome and the structure of HCV proteins. The results were interesting and showed that HCV has five rare codon clusters and these rare codon clusters may play an essential role in ensuring proper folding of the protein chain.

The HCV structural proteins, core, E1, and E2, were located at the amino terminus and nonstructural proteins, NS3, NS4A, NS4B, NS5A, and NS5B, were located at the carboxyl terminus. The deduced amino acid sequence of HCV nonstructural 2 shows that NS2 is a hydrophobic transmembrane protein, described to be involved in different functions.^[@R43],[@R48]^ NS2 is a 217 amino acid long cysteine-protease composed of a hydrophobic N-terminal membrane binding domain (MBD) and C-terminal globular and cytosolic protease subdomain. Previously a model of NS2 proposed that this protein is a polytopictrans membrane protein containing 3 putative transmembrane segments.^[@R43]^ Many studies have been done on this protein indicating interesting results regarding the role of amino acids.^[@R43]^ These studies show that alanine substitutions with aromatic residue in TMS2 (Y39) reduced infectivity titers up to 1,000-fold whereas mutations introducing electrostatic repulsion in TMS2 (E45R) blocked virus production .^[@R43]^

Also, for W35F and W35FNS3- Q221L, interaction of NS2 with other viral proteins reduced, but to different extents.^[@R43]^ Based on the model of the NS2, residues 25 and 39, which were found on TMS1 and TMS2, respectively, might be in contact.^[@R43]^ It assumed the ''hole'' created in TMS2 by the Y39A substitution was compensated by a bulky amino acid in the interacting TMS1 counterpart, thus 'filling up' the hole in the mutated TMS2. A striking correlation was found between reduction of aromaticity as well as size of residues at these sites (W35 and W36) and decrease of virus production arguing the aromatic side chains of W35 and W36 involved in essential interactions. These results show that these residues play critical roles in proper folding of this protein and disrupting this process severely affected the virus life cycle. An important point deduced from our analysis was that some of these residues were involved in rare codon clusters of NS2 ([figure 6](#F6){ref-type="fig"}).
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As mentioned, mutation of these residues blocks or reduces virus production and this shows that the situation of side chains are important in maintaining the HCV life cycle. NS2 has a rare codon cluster found in transmembrane (TMS2). According to the characteristics of transmembrane proteins, translation and folding of TMS2 mRNA appear to be more important and may take more time for folding compared with other parts of NS2. However, these conclusions should be confirmed with experimental evidence.

The 631-residue HCV NS3 protein is a dual-function protein, containing the trypsin/chymotrypsin-like serine protease in the N-terminal region and a helicase in the C-terminal region.^[@R49],[@R50]^ Co-transfection studies showed the NS3 serine protease domain, in absence of its C-terminal helicase counterpart, is mediating cleavage of polyprotein substrates.^[@R51]^ The minimal sequences needed for a serine protease activity determined by these groups is the N-terminal 180 amino acids of the NS3 protein. Deletion of up to 14 residues from the N terminus of the NS3 protein is tolerated, although a further deletion of the N-terminal 22 amino acids resulted in significantly poorer processing of HCV polyprotein. On the other hand, deletions from C terminus of this minimal serine protease domain abolished proteolytic activity.^[@R52],[@R53]^ Our study showed that NS3 protein has three rare codon clusters found in polyprotein extending from amino acids 1062-1069, 1096-1100 and 1132-1136 that lies between strands A1-B1, E1-F and A2-B2 in N-terminal domain of NS3. Full-length NS3 protein found from amino acids 1027 to 1658 of the polyprotein of the genotype 1b consensus sequence.^[@R54]^ Previously, in the protease domain of NS3, amino acid residues involved in substrate-binding pocket were identified.^[@R55]^ These residues are potentially able to interact with peptide substrates.^[@R55]^ Studies show that some of these residues are found in rare codon cluster locus ([figure 7](#F7){ref-type="fig"}).
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Most NS3 protease inhibitors are competitive with the substrate and thus target the substrate binding site.^[@R55]^ The earliest inhibitors were based on product peptides.^[@R56]^ Many positions of NS3 protease have shown to contribute to resistance in cell culture and in the clinic.^[@R55]^ Many of the positions confer resistance to both macro-cyclic and linear inhibitors.^[@R55]^ Amino acid substitutions at positions that are not essential for substrate binding would lead to drug-resistant proteases and viruses that do not debilitate for function.^[@R56]^ Our study showed that some of residues that involved in substrate binding site and confer resistance inhibitors can be found in the first rare codon cluster and near position of other rare codon cluster. As we know, the binding site residues are critical in enzymes and proper position of these residues should be adjusted accurately. These data show that positions of rare codon clusters may play a critical role in proper folding and action of protease domain of NS3.

HCV nonstructural protein 5A (NS5A) plays an essential role in viral genome replication. The protein is predicted to be mainly hydrophilic and to contain no transmembrane helices.^[@R46]^ A recent study using bioinformatics-assisted modeling suggested a three-domain organization ^[@R47]^ with domain I (a.a. 1-213) found in the N-terminal region, and Domain II (a.a. 250-342) and Domain III (a.a. 356-447) in the C-terminal region. The N-terminal 30 aa of NS5A predicted to form a conserved amphipathic alpha-helix.^[@R57]^ Afterwards, this structure has shown to be very essential for HCV RNA replication.^[@R45]^ Our study showed that NS5A protein has two rare codon clusters found in polyprotein extending from amino acids 2051-2061 and 2154-2157that lies in N-terminal domain (domain I) of NS5A. Full-length NS5A protein was found from amino acids 1978 to 24287 of the polyprotein of the genotype 6a consensus sequence. Previously, in the N-terminal domain of NS5A, the amino acid residues involved in activity were identified. The location of some of these residues and rare codon clusters is shown in [figure 8](#F8){ref-type="fig"}.
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As shown in this figure some of the residues found in the first rare codon cluster and near other rare codon clusters. Interestingly, an unconventional zinc-binding motif predicted to exist in the N-terminal domain, showing that NS5A is a zinc metalloprotein.^[@R47]^ The predicted zinc-binding motif involves four cysteine residues (C39, C57, C59, and C80), and includes a structural motif (CX17CXCX20C). This motif appeared critical for the structural stability and functions of NS5A protein, since mutation of any single cysteine residue in the motif disrupted the ability of NS5A to coordinate zinc and eliminated RNA replication.^[@R47]^ As we know these residues are critical in enzymes and proper position of these residues should be adjusted accurately. These data show that rare codon cluster may play a critical role in proper folding and action of protease activity. These data indicate that in HCV life cycle, rare codon clusters play an important role that must be investigated. However, other rare codon clusters may exist that could not be identified by Sherlocc program and require further study. Since most rare codon clusters were found in NS3, it appears that these clusters may play a more significant role than other HCV proteins.

As explained in the introduction, ribosomal pauses caused by rare codons can basically regulate specific folding events but could also be involved in other mechanisms involving the nascent polypeptide chain such as protein targeting or co-translational molecular recognition events.^[@R2]^ However, we cannot strictly state whether such pauses are needed for folding or molecular recognition of HCV proteins. Based on the involvement of families with rare clusters with membrane insertion or recognizing large complexes, it is suggested that those rare codon clusters are important in HCV life cycle. Proteins synthesized in a nonlinear kinetic landscape and mRNA sequence seem to carry more information than those necessary to encode protein sequences. Information that can be used for regulating folding events as well as regulating co-translational molecular recognition events such as recognizing signal peptides, formation of complexes, or membrane insertion. We believe that this study presents a new perspective in genome research of HCV. In the future, this study can also provide new fields in drug design for the treatment of HCV.
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